EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Molecular mechanisms of the Longjin Tonglin Capsule in the treatment of LPS-induced prostatic inflammation: Network pharmacology and experimental verification

Chao Chen, Libin Yang, Qianghui Wang, Tao Sun

Letters in Drug Design & Discovery · 2026-09 · 23 (9) · 100587

DOI: 10.1016/j.lddd.2026.100587 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Letters in Drug Design & Discovery, 2026-09. Verfasst von Chao Chen und 3 weiteren Autor:innen. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Zhejiang Medical Association.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Zhejiang Medical Association

Zitieren

APA

Chen, C., Yang, L., Wang, Q., & Sun, T. (2026). Molecular mechanisms of the Longjin Tonglin Capsule in the treatment of LPS-induced prostatic inflammation: Network pharmacology and experimental verification. Letters in Drug Design & Discovery, 23(9), 100587. https://doi.org/10.1016/j.lddd.2026.100587

Vancouver

Chen C, Yang L, Wang Q, Sun T. Molecular mechanisms of the Longjin Tonglin Capsule in the treatment of LPS-induced prostatic inflammation: Network pharmacology and experimental verification. Letters in Drug Design & Discovery. 2026;23(9):100587. doi:10.1016/j.lddd.2026.100587

BibTeX
@article{Chen2026,
  author = {Chen, Chao and Yang, Libin and Wang, Qianghui and Sun, Tao},
  title = {Molecular mechanisms of the Longjin Tonglin Capsule in the treatment of LPS-induced prostatic inflammation: Network pharmacology and experimental verification},
  journal = {Letters in Drug Design & Discovery},
  year = {2026},
  volume = {23},
  number = {9},
  pages = {100587},
  doi = {10.1016/j.lddd.2026.100587}
}
Kostenlos starten →